Business Investment Opportunities

Founded by a visionary with lifelong experience in the service industry (starting from age 10), our business bridges the gap between high-end corporate standards and the beauty industry. We have built a resilient, owner-driven, and system-oriented clinic that thrives on international referrals even in challenging economic climates. There are 6 permanent employees, additionally we have 1 freelance employee. Thanks to our 8-year track record and result-oriented approach, we maintain a very high customer retention rate. The business is managed via a professional, owner-independent appointment and CRM system. Operational & financial strength: - High Average Order Value (AOV): While serving a boutique group of 150-170 elite clients per month, our focus is on high-margin clinical treatments. Our AOV ranges between $600 - $750 (approx. 20k-25k TRY), with premium protocols reaching up to $4,500 per client. - Intercontinental referral network: We take pride in a loyal global clientele from the US, Europe, and the Gulf (Dubai). Our 'quality travels' philosophy has created a worldwide referral loop where clients from New York or Dubai return annually for our specialized treatments. - Digital authority: Our acquisition engine is powered by strategic Google Ads, top-tier Google Maps ratings from local guides, and viral TikTok content shared by international visitors discovering Istanbul. - Investment Intent: We are NOT looking to sell the business. We are seeking a strategic partner to scale this 8-year proven system into a flagship multi-story facility and transform it into a global brand. - Certifications: The business has Beauty specialist certificate, Mastery certificate and Medical license for the clinic.

Company located in Sumqayit and primarily focuses on the supply, installation and maintenance of manufacturing machinery spare parts. - Has approximately 50 clients from a variety of industries including casting, cement, food, and railways. - Work on 1,000+ projects per month. - The project value ranges from USD 100 to 10,000, depending on the project size. - The annual turnover for the business is approximately USD 200K, showcasing its current financial standing and revenue generation capacity. - The machines are outsourced but all the assembling is done in-house. - The company utilizes manual machines for its operations but is planning on upgrading to CNC machines as part of its expansion plans to increase sales and efficiency. - Additionally, the business is in the process of obtaining ISO and project marine certifications.

New company that is in the process of registration aims to build the world's largest, most efficient & sustainable BTC mining farms in the next three years. - We have an active Ethereum and AltCoin mining company in Germany, through which we have already gained experience in this business. - This company is the parent company of a German mining company. - Company has one director and has no liability. - We know what kind of machines, equipment and tools to buy to set-up the farm. We have started to look for the facility to set-up the mining farm. - Company is based in Cyprus and is listed by a management member based in Germany. - The business projects a monthly revenue of EUR 17.3 thousand after the investment. The revenue expectations are with the recent courses of cryptocurrencies. - The subsidiary company has a 6% EBITDA margin and had last year reposted sales of EUR 64.2 thousand.

Our firm is a registered agriculture company based in the Canary Island. - We are starting a farming business of growing all types of mushrooms including all exotic strains. - The land of 45,000 square meters has already been reserved by us and are seeking funds to kick start the project. - Target market: we plan to sell mushrooms to 7 canary islands both in packaged and raw material form. - There is a huge market opportunity for mushrooms in Europe. - The directors of the company holds over 25 years of industry experience. - Have all the required documents in place. - Founders have already invested EUR 600 thousand and they can further invest EUR 3 Million in the business.

The company is currently in the pre-revenue phase. - The company will act as a third-party KYC and compliance services provider. - It will be engaged by banks and NBFCs to conduct customer KYC processes. - Revenue will be generated through fixed-fee service contracts. - The company is registered as a private limited company with GST registration.

The company was created to implement a project for the construction of livestock complexes (LC) in the central part of Russia. - The first step involves the construction of a residential complex in the Vladimir region for 2,000 dairy cows. This will be a complete, waste-free cycle of raising livestock and obtaining a finished product is planned. - Dairy direction: This is the production of a line of dairy products: milk, cottage cheese, sour cream, butter, cheese, etc. For the production of the above food products, it is planned to purchase and install automated production lines, including bottling and packaging. - The second stage is planned to produce milk powder. - Project financial performance indicators: • Payback period 2 – 3 years. The income generation model is by the share of the investor, the shareholder. • Return on investment: From 3 years onwards – 100% per annum. The full cycle of investment turnover is 3 years. - The company has owned land on which this farm complex will be constructed.

This global biotechnology company specializes in cutting-edge allogeneic adult stem cell technology, uniquely positioned as the only FDA-approved entity worldwide, with the Drug Controller General of India (DCGI) approval in process. - The company manufactures clinical-grade stem cells under cGMP standards, providing vital materials for US-based and international clinical trials, hence establishing a strong foothold in the biotechnology sector. - With Investigational New Drug Approvals for several serious conditions, including acute myocardial infarction, chronic heart failure, and Alzheimer’s disease, the company focuses on innovative solutions for chronic ailments lacking effective treatments. - Its cell-based therapies are designed to enhance longevity and quality of life, particularly targeting rehabilitation for chronic stroke patients and those affected by diseases without available cures. - Operating for 24 years in California, the business has a robust track record and is actively seeking expansion opportunities in international markets, allowing for broader reach and impact. - Revenue is generated through multiple channels, including a sale of license model with annual royalty fees averaging around 15% revenue, alongside direct sales of stem cells to existing licensees that partner with hospitals and healthcare providers. - Major license sale deals over the years include up to $529 million with South Asian countries, $72 million with a Chinese firm, $21 million with a Mexican company, $20 million with a Russian entity, and $21 million with a Kazakh company, showcasing strong demand and financial viability. - As a result of focused and aggressive marketing efforts to sell licenses, our sales have increased by a wide margin. We expect to reach an annual turnover of USD 3 billion for the next CY. - Recently registered as a public limited company in India, the firm is planning to establish a local laboratory and operations, further strengthening its market presence in the biotechnology industry. - The workforce comprises around 50 full-time employees, supplemented by freelance and interns, enhancing operational flexibility and innovation in research and development. - The promoter is currently in India and oversees operations across both locations.

The business is strategically located in Culiacán, a region known for its agriculture, enhancing the relevance of its offerings in sustainable agriculture solutions. - The company is specialized in oxygen inductor formulations that protect crops at an intracellular level, leading to stronger, more vibrant plants. - Planning to introduce sustainable pre-digested fish and crustacean feed, the business stands as a unique market player with no direct domestic or international competition, creating significant competitive advantage. - Current monthly sales are positioned at $14,000 with in-house production, with a substantial projected growth to $200,000, contingent on the acquisition of investment for scaling production. - This investment proposition includes the purchase of essential machinery and raw materials and meeting increasing market demand. - Sales are currently driven through direct channels including Facebook, phone contacts, and emails, hinting at potential growth through expanded digital marketing and e-commerce strategies. - The business offers an exciting investment opportunity in a niche market segment with the potential to capitalize on current sustainability trends in agriculture and aquaculture.